Won't be a commercial diagnostic for use in the general populace but perhaps a predictive test to find those patients with mild cognitive impairment or pre-AD who will probably progress to moderate AD within 1-2 years. Might serve as a helping tool when enrolling patients to trials.
Market Data 
Markets 
AI
